The Swedish Paediatric Association’s Section for Paediatric Haematology and Oncology recommends that whole genome sequencing should be a clinical routine at diagnosis for all childhood cancer patients. “For GMS Childhood Cancer, the statement is a...
The Swedish Innovation Agency Vinnova has decided to fund the further development and implementation of the National Genomics Platform so that data generated in healthcare can be put to the greatest possible use. For healthcare, research and innovation. “This is...
A population-based study of 6,000 lung cancer patients shows that patients with the KRAS G12C mutation have a high risk of brain metastases. Surprisingly this is not linked to worse survival. The study was conducted by researchers affiliated with Genomic Medicine...
A new Swedish study shows that whole genome sequencing can detect clinically relevant genomic abnormalities in acute lymphoblastic leukemia, ALL, and has great potential to be implemented in the diagnostic setting. The study, conducted by researchers within the GMS...
Results from the first 117 children to receive whole genome sequencing through the national GMS Childhood Cancer project show that in 90% of cases, genetic changes of clinical significance were found. The extensive work was carried out by more than 30 researchers and...
För att ge den bästa upplevelsen använder vi teknologier som cookies för att lagra och/eller få åtkomst till enhetsinformation. Genom att samtycka till dessa teknologier kan vi behandla data såsom surfbeteende eller unika ID:n på denna webbplats.
Anpassa samtycke
För att ge den bästa upplevelsen använder vi teknologier som cookies för att lagra och/eller få åtkomst till enhetsinformation. Genom att samtycka till dessa teknologier kan vi behandla data såsom surfbeteende eller unika ID:n på denna webbplats.
